Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24153431 | 1.00 | APP (0.32) | APP | |
| SCHEMBL24047845 | 1.00 | APP (0.32) | APP | |
| SCHEMBL24048215 | 0.95 | APP (0.32) | APP | |
| SCHEMBL24047421 | 0.95 | — | — | |
| SCHEMBL24047969 | 0.93 | KDM4E (0.30) | — | |
| SCHEMBL24047824 | 0.93 | — | — | |
| SCHEMBL24152295 | 0.92 | ESR1 (0.33) | — | |
| SCHEMBL24152567 | 0.91 | CA12 (0.36) | — | |
| SCHEMBL24048107 | 0.91 | — | — | |
| SCHEMBL24151987 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| WO-2021261977-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021235830-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, AHR, CRY2 | APP 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.